FDA Issues Warning on Controversial MS Treatment
THURSDAY, May 10 (Healthday News) -- Doctors and patients need to be aware of the potential risk of injuries and death associated with an experimental treatment for multiple sclerosis called liberation therapy, the U.S. Food And Drug Administration said in an alert issued Thursday. read more..
source:http://yhoo.it/LvWR2K
No comments:
Post a Comment